key: cord-0026905-6185wkq1 authors: Qi, Guanpeng; Jiang, Kaiwen; Qu, Jiaming; Zhang, Aijun; Xu, Ze; Li, Zhaohang; Zheng, Xiaosong; Li, Zuojing title: The Material Basis and Mechanism of Xuefu Zhuyu Decoction in Treating Stable Angina Pectoris and Unstable Angina Pectoris date: 2022-01-31 journal: Evid Based Complement Alternat Med DOI: 10.1155/2022/3741027 sha: 36eb6c4f84f29e27c05ea0b53fb2bcf69490c26a doc_id: 26905 cord_uid: 6185wkq1 METHODS: Firstly, we used a network proximity approach to calculate and compare the effectiveness of the formula with that of Western drugs for each type of angina, including all targets and intersecting targets, from a topological perspective. Secondly, we compared the mechanisms of action of the two angina pectoris at three levels and five aspects, including conventional and modular analysis approaches. Thirdly, based on the unique functions of each angina in the complex heterogeneous network, we designed a reverse process for finding the material basis using dynamic, static, and enriched items as well as a total item. Finally, the designed inverse process, material basis, and mechanism of action were validated. RESULTS: The target network of Xuefu Zhuyu decoction is closer to the target network of each type of angina than that of Western drugs, and the intersection targets have a closer proximity. Comparison of the mechanisms of action showed that stable angina and unstable angina had 158 common targets, while the unique targets were 34 and 1, respectively. Modularity analysis showed that the GO similarity of target modules was highly correlated with KEGG similarity. We ended up with 67 compounds upregulated for stable angina and 47 compounds upregulated for unstable angina. Our results were validated by literature mining, high-volume molecular docking, and miRNA enrichment analysis. CONCLUSIONS: For both types of angina pectoris, Xuefu Zhuyu decoction is superior to Western drugs. A comparison of various aspects led to the unique mechanisms of action, from which the material basis of each type of angina was deduced. e principle of treating different diseases with the same treatment is a major feature of traditional Chinese medicine (TCM) treatment, reflecting the spirit of "treatment by syndrome differentiation" [1] . For example, the Qiang-Huo-Sheng-Shi decoction is effective in the treatment of both rheumatoid arthritis and osteoarthritis because they share a similar pathogenesis [2] . Another example is that although cardiovascular diseases and gastrointestinal diseases are diseases of different organs, they are molecularly related and, therefore, Sanhe decoction can modulate their common pathological processes [3] . Both of these examples illustrate that different diseases are treated in the same way due to the same pathogenesis in their development. is may be the rationale behind the law of treating different diseases together. e application of the rule of same treatment for different diseases is quite common, and its effectiveness has been tested in clinical practice [4] . However, there is still a lack of systematic methods for comparing the mechanisms of action of herbal formulas that conform to this rule in the treatment of different diseases. Looking for the differences in the mechanisms of action and exploring the material basis behind them could lead to a better understanding and development of the formula, as well as to a more precise and personalized treatment. Coronary heart disease is one of the leading causes of death worldwide, and angina is the main type of coronary heart disease [5] . Coronary angina is an ischemic heart disease that is common in clinical cases. ere are two types of angina. Stable angina (SA) is the more common form of angina and is associated with myocardial ischemia. Unstable angina (UA) is another, more severe form of angina, a heterogeneous clinical syndrome associated with a high risk of cardiac ischemic events and sudden death [6, 7] . Chinese medicine experts consider angina pectoris to be in the category of "xiong bi" in the TCM concept [8] , and its main pathogenesis is blood stasis. Xuefu Zhuyu decoction is a classic formula in the category of invigorating blood circulation and resolving blood stasis and is also a representative formula for treating different diseases together [9, 10] . A series of clinical studies and meta-analyses have shown that both the Xuefu Zhuyu decoction and the derived pills or capsules are effective in both stable and unstable angina pectoris and are more effective than the commonly used Western drugs, i.e., nitrates, in certain indices [11] [12] [13] . Moreover, this formula was authoritatively recommended by the National Medical Products Administration (NMPA) as the mainstream treatment for angina pectoris [5] . However, comparative studies on the mechanism of action of Xuefu Zhuyu decoction in the treatment of the two types of angina pectoris are rare, and studies examining the material basis for the different mechanisms of action have not been retrieved. e study of the mechanisms of action and material basis of the TCM principle of treating different diseases with the same treatment using Xuefu Zhuyu decoction for stable angina pectoris and unstable angina pectoris as a real case study is of great relevance. Network pharmacology explains the function and basis of complex biological systems from a network perspective. Based on the research idea of network pharmacology, we can calculate and compare the mechanism of action of this formula for treating two types of angina pectoris from a systematic, holistic, and modular perspective, by constructing the complex networks [14, 15] . In contrast to forward network pharmacology, the reverse network pharmacology approach allows for the reverse access to the targets and components at play in the complex networks constructed from the perspective of disease characterization and function [16] . e strength of binding of a compound to different targets can be expressed in terms of the results of molecular docking [17, 18] . Furthermore, a range of compounds in a prescription can be docked to target proteins of different diseases to reveal the therapeutic characteristics of the prescription for different diseases. In the present study, we used forward network pharmacology to investigate the mechanism of action of Xuefu Zhuyu decoction in the treatment of two types of angina pectoris. e reverse network pharmacology approach was then used to study the material basis. Bulk molecular docking was used to validate the reliability of the upregulated compounds screened for the two angina pectoris species. e comparison of the similarities and differences between the mechanism of action and the material basis is the basis for understanding the treatment of different diseases with the same treatment. e flow chart of this study is shown in Figure 1 . Bupleuri Radix (CH), Paeoniae Radix Rubra (CS), Chuanxiong Rhizoma (CX), Glycyrrhizae Radix Et Rhizoma (GC), Angelicae Sinensis Radix (DG), Rehmanniae Radix (DH), Carthami Flos (HH), Platycodonis Radix (JG), Achyranthis Bidentatae Radix (NX), Persicae Semen (TR), and Aurantii Fructus (ZK). It has the effects of promoting blood circulation, removing blood stasis, promoting qi, and relieving pain. e prescription mainly treats blood stasis syndrome in the chest [19, 20] . e chemical components of eleven herbs were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) [21] . e chemical components in the herbs were then screened according to Lipinski's rule [22] and the conditions of OB ≥ 30% and DL ≥ 0.18. Many studies have shown that molecules meeting OB ≥ 30% and DL ≥ 0.18 show better pharmacological properties [23] . In addition, components that meet Lipinski's five rules often have better pharmacokinetic properties and higher bioavailability during in vivo metabolism and are, therefore, more likely to be drug candidates [24] . As a result, 147 compounds were searched from eleven herbs, specifically from nine herbs, as detailed in Table S1 in the supplementary materials. e Venn diagram of the compounds contained in the nine herbs in this formula is shown in Figure 2 . e possible targets of the ingredients were collected using TCMSP, Drugbank, and erapeutic Target Database (TTD). A total of 125 compounds have targets. All proteins were derived from Homo sapiens and converted to standard gene names through the Uniprot database. ere are 1900 interactions between compounds and proteins. See Table S2 in the supplementary materials for details. e disease targets of stable angina and unstable angina were collected through GeneCards, TTD, and Rat Genome Database (RGD). See Table S3 in the supplementary materials for details. Targets. Small-molecule drugs for the treatment of these two types of angina pectoris were found in the MalaCards database [25] . e database collects drugs for the treatment of one disease and other concurrent diseases, for example, drugs for angina pectoris and hypertension. Information on therapeutic drugs is obtained from a range of databases such as DrugBank, Human Metabolome Database (HMDB), Drug Gene Interaction Database (Dgidb), and Pharmacogenomics Knowledgebase (PharmGKB) [26] . All the selected treatment drugs were approved or under investigation. We then searched their targets in the DrugBank database. e information on the targets has been supported by evidence from the literature to ensure that the information is reliable. Information on these drugs and targets is in Tables S4 and S5 in the supplementary materials. e protein-protein interaction data were obtained from the String database [27] . e species option was set to Homo sapiens, and the minimum connection score will be mentioned in the next section. Disconnected nodes in the network have been hidden. e data of GO and KEGG enrichment analysis were obtained through the clusterProfiler package (version 3.18.0) in the R software [28] . Both the p value and the q value calculated using the false discovery rate were less than 0.05. [29] . Drug target nodes usually locate in or near disease modules within the molecular network [30] . We used the network proximity index proposed by Menche et al. [31] to compare the network proximity of the formula targets and disease targets and the network proximity of approved drug targets and disease targets. where d A and d B represent the average shortest distance between nodes within networks A and B, respectively, while d AB represents the average shortest distance between nodes in network A and nodes in network B. e smaller the value of d AB , the closer the targets of the drugs are to the targets of the disease, which means that the drugs are more likely to have a therapeutic effect [32] . e average shortest distance was calculated using the igraph package (version 1.2.6) in R 4.0.2. Targets. We used the network proximity index described above to compare the targets of this formula with the disease targets of the two classes of angina pectoris and the targets of approved drugs. At the same time, to demonstrate that the intersection of the targets of the formula with the disease targets can be used in subsequent studies, the targets of the Chinese medicine and the targets of the Western medicine were taken to intersect with the disease targets separately to facilitate the comparison of topological similarity using the network proximity index again. In Section 3.1.2, we initially demonstrate that the intersection targets of the formula and the disease were closer to the disease targets than the full formula targets in terms of topical structure, so we then used the intersection targets for subsequent studies. e treatment of stable angina pectoris and unstable angina pectoris with Xuefu Zhuyu decoction belongs to the content of simultaneous treatment of different diseases in traditional Chinese medicine. After the effectiveness of this formula has been proven, it will be valuable to investigate the similarities and differences in the mechanisms of action of the formula in the treatment of the two types of angina pectoris. We explored the similarities and differences of the action mechanism of the formula in the two disease conditions from the three levels of ingredient, target, and function. Specifically, the five aspects of formula compound, target, compound-target, function, and target-function were compared for the two disease conditions. e results of the comparison of these five aspects are shown in Section 3.2. e therapeutic action of the formula is reflected in the functions produced by its numerous targets [33] . We next analyzed the function of the targets using network clustering and functional similarity methods. Two PPI-weighted networks were constructed to divide functional modules, and GO similarity [32] and KEGG similarity [34] were used to compare the mechanism of action of the formulas when treating stable angina versus unstable angina. Furthermore, we calculated the Spearman correlation coefficient between the GO similarity and KEGG similarity of the modules to explore the feasibility of using GO or KEGG for subsequent studies. [34] for stable angina and unstable angina were constructed based on the compound-target network (C-T), target-target network (T-T), and target-pathway network (T-P). To ensure that the target-target interactions were reliable, the interaction score was set to be greater than or equal to 0.9. e construction of the network and the reverse finding of ingredients in the network are carried out according to the following steps: (1) Constructing complex networks: two complex heterogeneous networks were constructed based on the compound-target network, target-target network, and target-pathway network. (2) Random walk with restart (RWR): random walk on two complex heterogeneous networks with all active compounds as seeds, with a restart probability of 0.7 as default [35] . e RWR algorithm was performed by package RandomWalkRestartMH (version 1.10.0) in R 4.0.2. (3) Score and ranking of results: we obtained the ranking of the importance of the pathways and obtained the common and unique pathways based on the process shown in Figure 3 . (4) Finding compounds in the network in reverse: based on the unique pathways obtained in the two disease conditions, the compounds are then found in the network in reverse. An algorithm was constructed to obtain the upregulated versus downregulated ingredients of the formula based on the ranking of the importance of the obtained compounds. e process is shown in Figure 4 . e degree values of the pathways were calculated independently in two large complex networks. e degree value of a pathway represents the number of genes contained in that pathway, and the degree value alone does not fully reflect the importance of the pathway. It has been shown that key genes in a pathway can play an important role in that pathway [36] , so we added experimentally identified human key genes [37] to the calculation of the degree values and used the following formula to calculate and rank the scores of the pathways. Subsequently, the process shown in Figures 3 and 4 was followed to find the compounds in the network in reverse. where S i is the degree value of a pathway and S max and S min represent the maximum and minimum values of the degree values of all pathways, respectively. S k represents the percentage of the number of key genes in the pathway. e value of fold enrichment is the ratio of GeneRatio to BgRatio and represents the extent to which the target under study is enriched in a particular pathway and the importance of that pathway. Fold enrichment was used as a score to rank the importance of the pathways, and then, the compounds were found according to the process shown in Figures 3 and 4. Items Was Devised. By integrating the three previous approaches based on complex networks, a formula including static, dynamic, and enriched items was devised to find the ingredients in the network in reverse. e form of the formula named total item is as follows: S, D, and F are referred to as static, dynamic, and enriched items, respectively, while T represents total item. Firstly, the values of S, D, and F are normalized according to equation (4) . ese three items were then given the same weight by default. Finally, the three items are summed to form the total item. We defined S, D, and F to represent the aforementioned S value, RWR score, and fold enrichment value, respectively. e subsequent process of finding compounds in the network in reverse is the same as in the first three parts. e unique pathways for the two disease conditions obtained from the scores of the three items, static, dynamic, and enrichment, and the total item were the source and key point of the designed reverse process. We compared the unique pathways obtained from the three items and the total item and next compared the compounds obtained from the reverse process. e comparison method is the repetition rate of the results for each item. e calculation of the repetition rate of a pathway is different from the calculation of the repetition rate of a compound because we have assumed that the repetition rate of a pathway may be large and the repetition rate of a compound may be low. In practice, however, for our reverse search process in complex networks, the lower the repetition rate of pathways, the better and the higher the repetition rate of compounds the better. So, with the aim of overturning the original hypothesis, we have devised the following six formulas. Firstly, the repetition rate of the pathways was calculated. Two multiplex-heterogeneous networks Compound-target networks (C-T) Target-target networks (T-T) Target-pathway networks (T-P) Ranked by the number of occurrences of the compounds Compounds up-regulated for stable angina Ranked by the number of occurrences of the compounds Difference in ranking of compounds Nodes in the T-T networks were considered only for their primary and secondary nodes. All rankings were calculated in descending order. 6 Evidence-Based Complementary and Alternative Medicine S p , D p , F p , and T p represent the set of unique pathways obtained from static, dynamic, enriched, and total items, respectively. Also, when calculating the duplication rates of compounds, they represent the set of upregulated compounds obtained from the abovementioned four items, respectively. When calculating the repetition rate of the compounds, Z 3 and Z 4 take of the following form: Docking. e compounds up-and downregulated in each of the two disease conditions were molecularly docked to the unique targets contained in each of the two diseases. e molecular docking software used was PyRx 0.8 and AutoDock Vina 1.1.2 [38] . If the overall binding of the upregulated compounds was better than that of the downregulated compounds, then it can be shown that our process of finding compounds in reverse in the network was essentially correct. In addition, to further confirm the plausibility of the designed inverse process, 50 compounds were randomly selected as random ingredients from the TCM@Taiwan database of over 60,000 compounds for molecular docking with the abovementioned targets without put-back sampling. e docking results of the random compounds were compared with the results of the upregulated compounds and the results of the downregulated compounds. In the end, we performed a total of 3990 molecular docking sessions. e specific comparison methods and binding are shown in the results section. Database. Most of the targets described above are protein products produced by the encoded genes. Considering the combined effects of target gene expression and regulation of target gene expression on disease function, miRNAs were explored as important regulators of the regulation of target gene expression [39] . Specifically, we obtained experimentally measured miRNA expression data for stable angina versus unstable angina from the Gene Expression Omnibus (GEO) database (GSE66752 and GSE94605). Specifically, firstly, we obtained data on experimentally measured miRNA expression in the GEO database for stable angina and unstable angina, and secondly, we performed differential expression analysis using the GEO2R analysis tool. e screening condition for miRNA was set to |logFC| >2 and p < 0.05 [40] . Afterwards, the miRabel database [41] was searched for miRNA targets that were experimentally confirmed and had a score of >0.5. Finally, KEGG enrichment analysis of target genes was performed using the clusterProfiler package (version 3.18.0) in R 4.0.2. e results of the miRNA functional enrichment analysis were compared with the results of the enrichment analysis of the crossover genes described above and with the results of the designed reverse process. If the duplication rate of the pathway is high, then it can indirectly prove that our forward process and reverse process are reliable. Studying the Intersectional Targets ere were 3321 and 1626 targets for stable angina and unstable angina obtained by searching the databases, respectively. e total number of targets for this formula after deduplication was 230. In addition, there are 398 and 221 targets for approved Western drugs for the two types of angina, respectively. Information on the formula, diseases, and approved Western drugs is recorded in detail in Table 1 . e network proximity approach compares the topological similarity of two dense networks, where the similarity Evidence-Based Complementary and Alternative Medicine of the topology of the two networks represents the possibility that the two networks perform some similar functions [42] . Specifically, we use the separateness method of the network proximity approach to measure the proximity of two networks [30] . In terms of equation (1), a smaller value of d AB represents a closer proximity of the two networks. e results in Table 2 present a comparison of the network proximity of this formula and approved Western drugs to each of the two angina pectoris. e results show that the targets of the formula are always closer to the targets of the disease than the targets of the Western drugs in terms of topology, for both stable and unstable angina. erefore, these results suggest that the treatment of both stable and unstable angina pectoris with Xuefu Zhuyu decoction is effective and superior to approved Western drugs. e results in Table 2 also illustrate that the intersection targets of the formula and diseases are closer to the disease targets than the intersection targets of Western drugs and diseases, and such results are consistent with the results in Section 3.1.1. In addition, a more important point illustrated in Table 2 is that when the targets of the drugs are taken to intersect with the targets of the two angina pectoris, the intersecting targets is closer to the targets of the disease, both for the formula and the Western drugs. Such results lead us to realize that their intersecting targets with the disease are feasible for the next studies, regardless of whether they are prescription or Western drugs. Subsequent studies with intersecting targets may lead to a more relevant material basis or mechanism of action for the disease. We calculated and compared the number of compounds that actually acted on the target in the two complex heterogeneous networks. We then also calculated and compared the number of intersecting targets on which the compounds acted and the number of enriched GOs and KEGGs derived from this extension. BP is the most numerous and dominant type of enrichment in GO enrichment analysis; therefore, we used GO-BP for the follow-up study [33] . In the screening conditions, p value and q value were set to less than 0.05. e results of the comparison of compounds, targets, and functional enrichment are shown in Table 3 . In terms of compound-target, that is, which types of targets the compounds acted on, we have analyzed the actual targets on which compounds act in the complex network. A comparison of the classification of target proteins in the two angina conditions is shown in Figure 5 (a). We can find that the targets common to both types of angina are mostly focused on enzymes, kinases, transcription factors, and signaling molecules. In comparison, there are no signaling molecules among the targets unique to stable angina, while the importance of G-proteincoupled receptors and enzyme modulators, for example, increases. e one target unique to unstable angina is currently not clearly classified. We then analyzed the classification of the pathways, and the results are shown in Figure 5 (b). As can be seen from the figure, the pathways common to both types of angina are classified in the main areas of signal transduction, the immune system, the endocrine system, specific types of cancer, and infectious diseases. e number of pathways included in each of these five broad pathway categories is greater than 10. Pathways unique to stable angina are classified in the areas of endocrine system, cancer, development, and regeneration, while pathways unique to unstable angina are classified in the areas of neurodegenerative disease, signal transduction, endocrine system, ageing, and specific types of cancer. We can conclude that both types of angina have a significant proportion of common components in terms of target classification and pathway classification, which may underlie their common pharmacological effects. at is, the common action on common targets and pathways produces a common mechanism of action. However, both classes of angina have a proportion of unique targets and unique pathways. Also, even within the common targets and pathways, the ranking of their importance is different. Modular Analysis. Modular analysis was used to compare the target-functional aspects of the two classes of angina [43] . We obtained the protein-protein interaction network (PPI) for stable angina and unstable angina on the basis of defaulting the intersection targets of the formula action as the therapeutic targets, and the interaction score was set to be greater than or equal to 0.4 to ensure that as much interaction information as possible was included. Next, the two PPI networks were divided into modules using the fast greedy algorithm, the infomap algorithm, and the walktrap algorithm, respectively [44] , and the interaction scores were used for weighting. In other words, this process actually clustered the two large weighted networks using each of the Targets Drugstargets Drugs-disease targets Stable angina 125 230 1900 1677 68 398 898 593 3321 Unstable angina 125 230 1900 1461 22 221 338 161 1626 8 Evidence-Based Complementary and Alternative Medicine three network clustering algorithms and then analyzed the modules obtained from the clustering. Our results have shown that both networks clustered with the fast greedy algorithm outperformed the other two algorithms on the metric of modularity index [44] , so we used the fast greedy algorithm for network clustering. e results of the comparison of the modularity index are presented in Table S8 in the supplementary materials. e results of the network clustering showed that both weighted PPI networks were divided into four modules, and we then compared these modules for GO similarity and KEGG similarity. For the specific calculations, the GO similarity was calculated using the GOSemSim package (version 2.16.1), while the KEGG similarity was calculated using the e results of the comparison of the functional similarity of the modules illustrate several conclusions. Firstly, the results of the comparison of GO similarity and KEGG similarity for each module are highly consistent. At this level, it can be shown that the use of either GO or KEGG to indicate the functions of the targets is reliable and that the two can be substituted for each other. Secondly, the modules for stable angina and unstable angina always cluster together, for example, SAcluster1 and UAcluster4, SAcluster2 and UAcluster1, SAcluster3 and UAcluster3, and SAcluster4 and UAcluster2. is suggests that stable angina and Evidence-Based Complementary and Alternative Medicine 9 unstable angina are very close in terms of the function of the divided modules, which may be the basis for the formula to work in treating different diseases together. Finally, there are still differences between the modules for stable angina and those for unstable angina. For example, in the clustering of GO similarity and KEGG similarity, SAcluster4 and UAcluster2 are clustered together, but the two functional similarities between the two modules are only 0.54 and 0.36, respectively. We then calculated the Spearman correlation coefficient between the two functional similarities, and the results show an extremely strong correlation. e results of the correlation coefficients are shown in Table 4 . Reverse Lookups in Networks 3.3.1. Scores for the ree Complex Network-Based Approaches. Running the restart random wandering algorithm in a constructed complex network gives the score of a node or some nodes (seed nodes) with any other nodes, and this score can indicate the strength of the relationship between the nodes [45, 46] . e meaning of restart can be equated to the fact that the seed node may or may not perform a wander; i.e. it is given a restart probability before performing a wander. We performed restart random wandering in two complex heterogeneous networks using all the compounds that acted as seed nodes and then obtained the scores of these seed nodes on the pathways. A schematic of these two random walks is shown in Figures 7(a) and 7(b) . We have shown in the previous section that GO similarity correlates extremely well with KEGG similarity, so in enrichment analysis, either GO or KEGG enrichment analysis can be used to represent the therapeutic effect produced by the targets. erefore, we chose the results of the KEGG enrichment analysis as the source for the reverse process of the enrichment term. e results of the KEGG significant enrichment analysis are shown in Figures 8(a) and 8(b) . In practice, we used the ratio of GeneRadio to BgRadio to represent the scores of enriched terms. We found that these three complex network-based approaches had different emphases in their scores across all pathways. e dynamic, static, and enrichment terms all had their own tendency to score high on the pathways. In other words, each pathway has a different tendency to score differently on the dynamic, static, and enrichment terms, and we have drawn a graph of the tendency to score differently on the pathways in Figures S1 and S2 in the supplementary materials. However, all three items are important. erefore, we designed a total item combining dynamic, static, and enrichment items to indicate the importance of the pathways. e basis and focus of the scores for dynamic, static, and enrichment items are different, as can be seen from the ranking of the importance of the pathways. As can be seen in Figure 9 (a), the unique pathways for stable angina and unstable angina that we obtained based on the scores for the three items mentioned above have a repeat rate 10 Evidence-Based Complementary and Alternative Medicine HIF1A HMOX1 HSPB1 ICAM1 IFNG IGF2 IGFBP3 IKBKB IL10 IL1A IL1B IL2 IL4 IL6 INSR IRF1 hsa05030 hsa05031 hsa04723 hsa04520 hsa00140 hsa04913 hsa04610 hsa04730 hsa04724 hsa04960 hsa00590 hsa00330 hsa03320 DPP4 PTGS1 TOP2A TP53 TYR ACHE CYP1B1 F7 MAOB NR1I2 ODC1 PLAT PLAU PON1 PPARD RASSF1 RUNX1T1 SCN5A SOD1 THBD VCAM1 XDH PTPN1 HSD3B2 SLC6A3 SLC6A4 SLC6A2 CA2 SMAD3 SYK CHRNA7 SELL ABCC1 GSR HMGCR MTTP SOAT1 SREBF1 CD163 TIMP1 (a) HIF1A HMOX1 HSPB1 ICAM1 IFNG IGF2 IGFBP3 IKBKB IL10 IL1A IL1B IL2 IL4 IL6 INSR IRF1 of less than 47%. e majority of the results are only 40% and below. ere are three formulas used to calculate the repeat rate of unique pathways, numbers 1, 2, and 3, corresponding to equations (6), (8) , and (10), respectively. Equations (8) and (10) were calculated using different numerators and denominators, and the results represent the two extreme values of the maximum and minimum values for this calculation condition. In Figure 9 (b), the results of the pathways with the total term are added to the calculation, so numbers 1, 2, and 3 correspond to equations (7), (9) , and (11), respectively. Equations (9) and (11) also represent the maximum and minimum values for that calculation condition, respectively. As can be seen in Figure 9 (b), when the results of the pathway for the total term were added to the calculation, the repetition rate calculated by equation (9) is suddenly much higher. Such results suggest that the total term is the result of a combination of dynamic, static, and enrichment terms and that the scores for the importance of the pathways bring together the characteristics of each of these three terms. However, despite the different focus of the pathway scores and the relatively low repetition rates of the pathways, the compounds obtained from the reverse process all have repetition rates close to or above 70%, with some results close to or even above 90%. ese results indicate that the upregulated compounds obtained for that disease condition are always relatively consistent, whether they are dynamic, static, enriched, or total terms. In other words, the functions played by some important and unique compounds encapsulate the functions characterized by the dynamic, static, enrichment, and total terms. All four processes for finding compounds in reverse in the network based on the four items mentioned above are feasible because of the high duplication rate of the upregulated compounds found. e unique pathways for the two types of angina obtained from the dynamic or static or enriched terms were different, and we took duplicate values for the results obtained based on the three mentioned above, i.e., the unique pathways calculated for all three mentioned above. As for the total term, we found that the results of all three terms after taking duplicate values were in the results of the total term, for both types of angina. is is another indication that the results of the total term are a fusion of the results of the three previous terms. e unique pathways for both angina categories are shown in Figures 10(a) and 10(b) . We can see that some pathways are unique for both angina categories; however, their importance ranking is different, see Tables S9 and S10 in the supplementary materials. e node size in the figure refers to fold enrichment, i.e., the relative enrichment of the target in that pathway, not the importance ranking. After reverse search and calculation, there were 67 and 47 upregulated compounds for stable angina and unstable angina, respectively. In fact, the upregulated compounds for stable angina are the downregulated compounds for unstable angina and vice versa. To further demonstrate the reliability of the designed inverse process, we increased the screening condition among the upregulated compounds to find selected compounds, as described in Tables S12 and S13 in the supplementary materials. e screening condition was that the importance rank of the upregulated compounds was greater than the median of the importance rank, resulting in 30 selected upregulated compounds for stable angina and 19 selected upregulated compounds for unstable angina. Both the upregulated compounds and the selected upregulated compounds are in Tables S12 and S13 in the supplementary materials. We next validated both the upregulated compounds and the selected upregulated compounds. (7), (9) , and (11), respectively. In terms of literature mining for therapeutic efficacy, i.e., whether it works, the literature validation rate ranged from 20% to 30%, with some results above 30%. From the results in Figure 11 (a), it appears that the literature validation rate for selected upregulated compounds is higher than for unselected upregulated compounds. is suggests that the proportion of upregulated compounds with literature evidence of association with cardiovascular disease has increased after more stringent screening. In terms of the mechanism of action, i.e., how it worked, the literature validation rate for which targets the compounds acted on was slightly lower, between 10% and 30%, as shown in Figure 11 (b). However, the literature validation rate for selected upregulated compounds in stable angina was still higher than for unselected compounds, still supporting the abovementioned pattern. It is important to note that the absence of literature evidence supporting an association with cardiovascular disease or with those targets collected does not mean that the compound does not have a therapeutic function in angina, as the compound may act on other aspects of the body to produce efficacy in angina [47] . For example, most compounds have been searched in the literature in relation to inflammatory, hormonal, and psychiatric disorders [48] [49] [50] . ere are also approved Western drugs that treat angina through hormonal and psychiatric aspects [51, 52] . Overall, the upregulated compounds obtained by reverse search in the network and subsequent comparative analysis were supported by a certain amount of literature in terms of therapeutic effects and mechanisms of action. Nearly a quarter of all compounds in the formula were also validated in the literature. Moreover, selected upregulated compounds had a higher percentage of literature validation than unselected upregulated compounds. Classes of Compounds. We performed molecular docking of upregulated compounds, downregulated compounds, selected upregulated compounds, selected downregulated compounds, and random compounds with unique targets for the two classes of angina. Detailed values of the docking results are shown in Table S14 in the supplementary materials, and folded line graphs are shown in Figures 12(a) and 12(b) . e IDs and names of the upregulated compounds and selected upregulated compounds are listed in Tables S12 and S13 in the supplementary materials. Alternatively, the randomly selected compounds can be found in Table S15 in the supplementary materials. e target section presented in Table 3 shows 34 unique targets for stable angina and 1 unique target for unstable angina. ese unique targets are the respective difference sets of these two angina targets after removing the intersection. Detailed information on the Gene Symbols of the unique targets and the molecular docking results is also included in Table S14 in the supplementary materials. For example, the unique targets for stable angina include CASP7 and SLC2A4, while the target for unstable angina is NCF1. Specifically, a total of 114 up-or downregulated compounds, 49 selected up-or downregulated compounds, and 50 randomly selected compounds were molecularly docked to 35 unique targets in stable angina or unstable angina. In terms of numbers, we performed a total of 3990 molecular docking exercises. Each unique target was studied, and the mean value of the binding capacity of all compounds docked to that target was used as a criterion for determination. For unique targets in stable angina, a target was labelled if the ranking of binding capacity was random compounds